Loading
Waverley Pharma Inc. Stock: price and insider trades · Canada
Waverley Pharma Inc.: what insiders have been doing
Waverley Pharma Inc., classified in the Health Care sector, is a listed company. Its insiders report their share dealings to SEDI. Over the twelve months to 23 October 2026, 1 filing were filed, from 1 insider.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
No insider has bought Waverley Pharma Inc. shares on the open market in the past twelve months.
Across the 2,469 companies tracked on its exchange, the median is 12 filings; at 1 filing, this issuer sits below that mark. Our records for Waverley Pharma Inc. go back to 2017, with 11 purchases and no sales on the open market in total.
These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Insider Decl.
17
Thresholds
n/a
Buy Volume
€9,543
11 ops. · all time
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
CA$0.01
Analyst consensus
Income statement
RevenueCA$1.3M
Gross profitCA$513.7k38% margin
EBITDA-CA$130.7k-10% margin
Net income-CA$499.2k-63.4% margin
Valuation
Beta1.46
Balance sheet & cash
Total debtCA$3.4M
Free Cash Flow-CA$611k
Profitability & ownership
ROA-28.1%
% insiders74.9%
% institutions0.0%
Last declaration on 19 August 2026
Declarations17 total
10,000,000 shares@ CA$0.11100.0% of flowWarrantsTSXSEDI:4766415
12,000 shares@ CA$0.155Common SharesTSXSEDI:3604051
Canonical exit: 20 Dec 2020 (T+90)
Common SharesTSXSEDI:3601123
10,000 shares@ CA$0.16Common SharesTSXSEDI:3601126
Canonical exit: 10 Dec 2020 (T+90)
5,000 shares@ CA$0.100.0% of flowCommon SharesTSXSEDI:3418164
Canonical exit: 28 Nov 2019 (T+90)
10,000 shares@ CA$0.120.1% of flowCommon SharesTSXSEDI:3410596
Canonical exit: 12 Nov 2019 (T+90)
500 shares@ CA$0.100.0% of flowCommon SharesTSXSEDI:3410594
Canonical exit: 12 Nov 2019 (T+90)
10,000 shares@ CA$0.1450.1% of flowCommon SharesTSXSEDI:3408983
Canonical exit: 7 Nov 2019 (T+90)
3,000 shares@ CA$0.120.0% of flowCommon SharesTSXSEDI:3387481
Canonical exit: 19 Sept 2019 (T+90)
4,500 shares@ CA$0.100.0% of flowCommon SharesTSXSEDI:3387480
Canonical exit: 19 Sept 2019 (T+90)
37,000 shares@ CA$0.100.4% of flowCommon SharesTSXSEDI:3385754
Canonical exit: 16 Sept 2019 (T+90)
8,000 shares@ CA$0.28Common SharesTSXSEDI:3288288
Canonical exit: 27 Mar 2019 (T+90)
4,000 shares@ CA$0.27Common SharesTSXSEDI:3288289
Canonical exit: 27 Mar 2019 (T+90)
Common SharesTSXSEDI:3288287
500,000 shares@ CA$0.425Common SharesTSXSEDI:3197532
Common SharesTSXSEDI:3074313
40,000,000 shares@ €0.3354Common SharesTSXSEDI:3074321
17 of 17 declarations
About Waverley Pharma Inc.
Waverley Pharma Inc. is a company focused on the development of pharmaceutical products. It is listed on the Toronto Stock Exchange under the symbol XTSE.
